SDC1 and COVID-19: Vascular endothelial damage has been identified as a common feature of high-risk patients prone to severe COVID-19, and several studies have shown that endothelial glycocalyx is seriously damaged during COVID-19, as proved by the increased shedding of syndecan-1 and hyaluronic acid and increased levels of heparanase [66,84].